Inventor · disambiguated record
Burghardt Wittig
Also filed as: WITTIG BURGHARDT
15 granted patents·7 pending applications·298 citations·filing 1995–2022
93Inventor score
Files withMOLOGEN AG9WITTIG BURGHARDT3MOLOGEN FORSCHUNGS ENTWICKLUNG2SCHROFF MATTHIAS2DOBRIC TOMISLAV1
Top patents by PatentIndex Score
22 records- 0195US6451563B1Method for making linear, covalently closed DNA constructsMOLOGEN FORSCHUNGS ENTWICKLUNG·Filed 2000·Granted Sep 17, 2002·122 cites·23 claims
- 0288US6849725B2Covalently closed nucleic acid molecules for immunostimulationMOLOGEN FORSCHUNGS ENTWICKLUNG·Filed 2002·Granted Feb 1, 2005·39 cites·8 claims
- 0386US8017591B2Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animalsMOLOGEN AG·Filed 2006·Granted Sep 13, 2011·13 cites·11 claims
- 0485US7635468B2Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccineMOLOGEN AG·Filed 2006·Granted Dec 22, 2009·13 cites·4 claims
- 0584US9212366B2Immune modulating oligonucleotides in connection with chemotherapeutic measuresWITTIG BURGHARDT·Filed 2005·Granted Dec 15, 2015·9 cites·8 claims
- 0683US9499815B1Multimer for immunostimulationSCHROFF MATTHIAS·Filed 2007·Granted Nov 22, 2016·12 cites·9 claims
- 0780US10280424B2Covalently closed non-coding immunomodulatory DNA constructMOLOGEN AG·Filed 2015·Granted May 7, 2019·5 cites·5 claims
- 0880US6451593B1Design principle for construction of expression constructs for gene therapySOFT GENE GMBH·Filed 1999·Granted Sep 17, 2002·55 cites·32 claims
- 0979US7074772B2Design principle for the construction of expression constructs for gene therapyMOLOGEN AG·Filed 2002·Granted Jul 11, 2006·9 cites·20 claims
- 1077US10006032B2Predictive biomarker for cancer therapyMOLOGEN AG·Filed 2014·Granted Jun 26, 2018·4 cites·6 claims
- 1174US9345754B2Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccineDOBRIC TOMISLAV·Filed 2009·Granted May 24, 2016·4 cites·20 claims
- 1260US2024285671A1Sequential innate and adaptive immune modulation for cancer treatmentGENTECHNOLOGIESTIFTUNG DR GEORG UND INGEBURG SCHEEL STIFTUNG·Filed 2022·Application pending·0 cites
- 1349US2004138115A1Local pain-combating agentWITTIG BURGHARDT·Filed 2003·Application pending·0 cites
- 1447US7795406B2Agent for treating leishmania infectionsMOLOGEN AG·Filed 2005·Granted Sep 14, 2010·0 cites·3 claims
- 1546US2020385732A1Biomarker for small cell lung cancer therapyMOLOGEN AG·Filed 2018·Application pending·0 cites
- 1645US8669100B2DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane proteinWITTIG BURGHARDT·Filed 2010·Granted Mar 11, 2014·0 cites·4 claims
- 1744US6348338B1Method to separate cells that have been modified with superparamagnetic particles by ballistic transferFiled 1995·Granted Feb 19, 2002·5 cites·12 claims
- 1844US2010303803A1Catenate for immunostimulationMOLOGEN AG·Filed 2008·Application pending·0 cites
- 1944US2009220931A1Functional in vitro immunoassayMOLOGEN AG·Filed 2006·Application pending·0 cites
- 2042US2003157059A1Feline interleukin-12 as immunostimulantFiled 2002·Application pending·0 cites
- 2129US2012093804A1Concatamers for ImmunemodulationSCHROFF MATTHIAS·Filed 2010·Application pending·0 cites
- 2227US5853663APressure distributor and multi-macrocarrier assembly for ballistic transfer transfection apparatusFiled 1996·Granted Dec 29, 1998·8 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Burghardt Wittig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →